Royal DSM N.V., the Dutch company involved in life sciences and materials sciences, will make a $110 million investment into North China Pharmaceutical Group Corporation Ltd. of Shijiazhuang, Hebei Province. The investment will establish three joint ventures, two in the area of anti-infectives, and a third to build a vitamin C production facility. After the investment, Royal DSM will own 10% of NCPC Group Co. DSM will hold a 51% interestin the anti-infective JVs, but its interest in the vitamin C production JV will be 30%. More details...

Stock Symbols: (AMS: DSM) (SHA: 600812)